These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34795921)

  • 1. Emerging roles of left ventricular assist device therapy as bridge to transplant in an Asian city with scarce heart transplant donor.
    Wong KL; Ho KLC; Lee OJ; Lun KS; Bhatia I; Tam WYE; Fan YYK; Au WKT
    J Thorac Dis; 2021 Oct; 13(10):5717-5730. PubMed ID: 34795921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right and left ventricular assist devices are an option for bridge to heart transplant.
    Barac YD; Toledano R; Jawitz OK; Schroder JN; Daneshmand MA; Patel CB; Aravot D; Milano CA
    JTCVS Open; 2022 Mar; 9():146-159. PubMed ID: 36003474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Continuous Flow Left Ventricular Assist Device on Heart Transplant Candidates: A Multi-State Survival Analysis.
    Carrozzini M; Bottio T; Caraffa R; Bejko J; Bifulco O; Guariento A; Lombardi CM; Metra M; Azzolina D; Gregori D; Fedrigo M; Castellani C; Tarzia V; Toscano G; Gambino A; Jorgji V; Ferrari E; Angelini A; Gerosa G
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study.
    Tenge T; Roth S; M'Pembele R; Lurati Buse G; Boenner F; Ballázs C; Tudorache I; Boeken U; Lichtenberg A; Neukirchen M; Huhn R; Aubin H
    Life (Basel); 2022 Nov; 12(12):. PubMed ID: 36556331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous-flow left ventricular assist device versus orthotopic heart transplantation in adults with heart failure: a systematic review and meta-analysis.
    Zhang B; Guo S; Ning J; Li Y; Liu Z
    Ann Cardiothorac Surg; 2021 Mar; 10(2):209-220. PubMed ID: 33842215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical circulatory support pathways that maximize post-heart transplant survival.
    Karamlou T; Gelow J; Diggs BS; Tibayan FA; Mudd JM; Guyton SW; Slater MS; Song HK
    Ann Thorac Surg; 2013 Feb; 95(2):480-5; discussion 485. PubMed ID: 22921240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis.
    Theochari CA; Michalopoulos G; Oikonomou EK; Giannopoulos S; Doulamis IP; Villela MA; Kokkinidis DG
    Ann Cardiothorac Surg; 2018 Jan; 7(1):3-11. PubMed ID: 29492379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities and outcomes of left ventricular assist device implantation as a bridge to heart transplantation.
    Okoh AK; Selevanny M; Singh S; Hirji S; Singh S; Al Obaidi N; Lee LY; Camacho M; Russo MJ
    ESC Heart Fail; 2020 Oct; 7(5):2744-2751. PubMed ID: 32627939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marginal Improvement in Survival Post-Heart Transplantation in Patients With Prior Left Ventricular Assist Device: A Temporal Analysis of United Network of Organ Sharing Registry.
    Pal N; Stansfield J; Mukhopadhyay N; Nelson M
    J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):392-400. PubMed ID: 31679997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.